Skip to content
Screener

Twist Bioscience Corporation TWST Common stock, par value (in dollars per share)

Common stock, par value (in dollars per share) at other companies

Azenta logo
AzentaAZTA
$0.01
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$00.0%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
Danaher logo
DanaherDHR
Agilent Technologies logo
Agilent TechnologiesA
GeneDx Holdings logo
GeneDx HoldingsWGS

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$7.25B+335%
Enterprise value$7.24B+365%
P/S17.7×+13.1×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Reported directly by Twist Bioscience Corporation in its filing.

Tagged under the XBRL concept us-gaap:CommonStockParOrStatedValuePerShare.

The source filing: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q1 2026
Accession
0001581280-26-000040
(In thousands, except per share data)March 31,2026September 30,2025
Total liabilities$221,120$168,903
Commitments and contingencies (Note 11)
Stockholders’ equity
Common stock, $0.00001 par value —200,000 and 200,000 shares authorized at March 31, 2026 and September 30, 2025, respectively; 62,154 and 60,632 shares issued and outstanding at March 31, 2026 and September 30, 2025, respectively$1
Additional paid-in capital1,849,8381,793,163
Accumulated other comprehensive loss(639)(627)
Accumulated deficit(1,394,106)(1,319,578)
Total stockholders’ equity$455,094$472,958

Item 1. Financial Statements (unaudited)

FAQ

What is Twist Bioscience Corporation's common stock, par value (in dollars per share)?
Twist Bioscience Corporation (TWST) reported common stock, par value (in dollars per share) of $0 in Q1 2026.
How has Twist Bioscience Corporation's common stock, par value (in dollars per share) changed year-over-year?
Twist Bioscience Corporation's common stock, par value (in dollars per share) decreased by 0.0% year-over-year, from $0 to $0.
What is the long-term trend for Twist Bioscience Corporation's common stock, par value (in dollars per share)?
Over 4 years (2021 to 2025), Twist Bioscience Corporation's common stock, par value (in dollars per share) has grown at a 0.0% compound annual growth rate (CAGR), from $0 to $0.

Ask your AI about Twist Bioscience Corporation's common stock, par value (in dollars per share).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude